Penpulimab combined with rituximab, high-dose methotrexate, and cytarabine (Pen-RMA) in newly diagnosed primary central nervous system lymphoma (PCNSL): a phase 2 trial
青霉素单抗联合利妥昔单抗、大剂量甲氨蝶呤和阿糖胞苷(Pen-RMA)治疗新诊断的原发性中枢神经系统淋巴瘤(PCNSL):一项 II 期试验
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-026-01450-w
Shen, Hao-Rui; Wu, Jia-Zhu; Yin, Hua; Du, Kai-Xin; Sibusiso, Luthuli; Wu, Yi-Fan; Hua, Wei; Li, Yue; Kong, Yi-Lin; Zhang, Xin-Yu; Gao, Rui; Li, Jian-Yong; Wang, Li; Liang, Jin-Hua; Xu, Wei